Amin Mehrabian

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy

Elaheh Mirhadi, Mohammad Mashreghi, Anis Askarizadeh et al. · Scientific Reports · 2022 · 46 citations · Full text

Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma

Naghmeh Shahraki, Amin Mehrabian, Shahrazad Amiri-Darban et al. · Colloids and Surfaces B Biointerfaces · 2021 · 39 citations

Leptin-derived Peptide, Pegylated Liposomal Doxorubicin, Drug Targeting +10

Machine learning approaches for classification of colorectal cancer with and without feature selection method on microarray data

Elham Nazari, Mehran Aghemiri, Amir Avan et al. · Gene Reports · 2021 · 32 citations

Feature Selection Method, Data Classification, Engineering +14

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani et al. · IET Nanobiotechnology · 2022 · 28 citations · Full text

<scp>Anti‐</scp> epithelial cell adhesion molecule <scp>RNA</scp> aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model

Mohammad Mashreghi, Parvin Zamani, Maryam Karimi et al. · Biotechnology Progress · 2020 · 26 citations